Belite Bio (BLTE) Shares Outstanding (Weighted Average) (2020 - 2026)

Belite Bio's Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $400.0 billion for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $400.0 billion; the TTM figure through Mar 2026 stood at $400.0 billion (changed 0.0% YoY), while the FY2025 annual figure was $33.5 million, up 9.82% from the prior year.
• Shares Outstanding (Weighted Average) was $400.0 billion for Q1 2026 at Belite Bio, up from $33.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $400.0 billion in Q1 2023 to a low of $169302.0 in Q4 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $285.7 billion across 5 years, with a median of $400.0 billion in 2023.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) plunged 98.23% in 2022, then soared 15607.83% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $169302.0 in 2022, then jumped by 15607.83% to $26.6 million in 2023, then gained by 14.83% to $30.5 million in 2024, then grew by 9.82% to $33.5 million in 2025, then soared by 1192571.27% to $400.0 billion in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $400.0 billion (Q1 2026), $33.5 million (Q4 2025), and $400.0 billion (Q3 2025), per Business Quant data.